Healthcare and Life Sciences Leaders Build on NVIDIA to Advance Drug Discovery and Expa…

Healthcare and Life Sciences Leaders Build on NVIDIA to Advance Drug Discovery and Expand Patient Care

NVIDIA and the UW Medicine Institute for Protein Design debut RFD4-Proteina, a new open model that combines programmable protein design with search capabilities, unlocking new frontiers in biology.

Siemens Healthineers is advancing the next generation of adaptive radiotherapy, using NVIDIA intelligence to increase access to life-saving cancer care with agentic co-planning, patient-specific simulation and robotic control.

Automata, Benchling, Biolevate, Boltz, Danaher, Hologen and Therna Biosciences are using the NVIDIA BioNeMo open platform to develop scientific agents that connect drug design, autonomous laboratories and biological discovery, helping researchers move from hypothesis to experiments faster. | $NVDA